Moderate to Severe Atopic Dermatitis Study
Have you had moderate to severe atopic dermatitis for at least 1 year?
A clinical trial designed to evaluate the safety and effectiveness of a new investigational medication under development for adult patients with moderate to-severe atopic dermatitis is currently being conducted.
All subjects will receive injections of trial medication every other week for up to 32 weeks. For all trial participants, the trial will include up to 20 visits to the trial clinic.
Atopic dermatitis is a chronic inflammatory skin disease. In its severe form, atopic dermatitis is characterized by widespread skin lesions, itch, as well as increased risk of skin infections. Atopic dermatitis is associated with a substantial burden that typically includes poor quality of life, sleep disturbance, and reductions in work productivity. There is no cost to participate in this clinical study and reasonable travel expenses will be reimbursed.
If you have type moderate to severe atopic dermatitis and want to know more about participating in this study, please fill out the form below or call us at (423) 308-3008.